Filter Results:
(1,488)
Show Results For
- All HBS Web
(1,488)
- People (1)
- News (333)
- Research (795)
- Multimedia (8)
- Faculty Publications (574)
Show Results For
- All HBS Web
(1,488)
- People (1)
- News (333)
- Research (795)
- Multimedia (8)
- Faculty Publications (574)
- 01 Jun 2006
- News
Social Enterprise Conference Draws 800 Participants
moderators and discussants. The panels examined aspects of education, the environment, finance and philanthropy, health care, international development, public policy, and technology. A “Pitch for Change”... View Details
- Web
Past Projects | Social Enterprise | Harvard Business School
level. The global community tends to look to governments and multilaterals during public health crises, but in what contexts can the private sector be better equipped to act and in what ways? ArcelorMittal (AM), an integrated steel and... View Details
- Web
Education Sector Opportunities at HBS - MBA
Business & Environment Career Change Career and Professional Development Case Method Clubs Curriculum Digital Entrepreneurship FIELD Financial Aid Health Care Instagram Takeover JD/MBA Leadership Letters to Classmates MBA/MPP & MBA/MPA-ID... View Details
- October 2020 (Revised March 2021)
- Supplement
Migros Turkey: Scaling Online Operations During COVID-19 (C)
By: Antonio Moreno and Gamze Yucaoglu
The case opens in August 2020 as Ozgur Tort and Mustafa Bartin, CEO and chief large-format and online retail officer of Migros Ticaret A.S. (Migros), Turkey’s oldest and one of its largest supermarket chains, are navigating Migros through COVID-19 and the unprecedented... View Details
Keywords: Business Model; Strategy; Digital Platforms; Information Technology; Technology Adoption; Value Creation; Globalization; Competition; Expansion; Logistics; Profit; Resource Allocation; Diversification; Corporate Strategy; Crisis Management; Health Pandemics; Strategic Planning; Food and Beverage Industry; Turkey
Moreno, Antonio, and Gamze Yucaoglu. "Migros Turkey: Scaling Online Operations During COVID-19 (C)." Harvard Business School Supplement 621-062, October 2020. (Revised March 2021.)
- January 2022 (Revised August 2022)
- Case
Hello Heart: The Next Generation of Chronic Disease Management Apps
By: Ariel D. Stern and Danielle Golan
Hello Heart, a hypertension management app debated whether to go deep and cover other heart conditions, or to expand its solution to other chronic conditions. View Details
Keywords: Health; Health Care and Treatment; Information Technology; Mobile and Wireless Technology; Analysis; Business Startups; Transition; Customer Focus and Relationships; Customer Satisfaction; Decision Making; Demographics; Design; Entrepreneurship; Venture Capital; Technological Innovation; Growth and Development Strategy; Product Launch; Product Design; Product Development; Business Strategy; Competitive Strategy; Competitive Advantage; Customization and Personalization; Business Growth and Maturation; Business Model; Strategy; Applications and Software; Health Industry; Health Industry; Israel; United States
Stern, Ariel D., and Danielle Golan. "Hello Heart: The Next Generation of Chronic Disease Management Apps." Harvard Business School Case 622-061, January 2022. (Revised August 2022.)
- 01 Jan 2006
- News
Sir Ronald M. Cohen, MBA 1969
Asia, and Israel, it has an international presence and a record of big hits that began in the 1980s with companies such as AOL and Apple and continues to this day with investments in industries as diverse as high tech and health care,... View Details
- September 2009 (Revised September 2010)
- Case
Avid Radiopharmaceuticals and Lighthouse Capital Partners
By: Matthew Rhodes-Kropf and Ann Leamon
In fall 2008, a venture lender must decide whether to make a loan to Avid, a small but promising venture-backed life sciences firm. In reviewing her proposal, Cristy Barnes considers the company's characteristics and how they differ from a typical investment. At the... View Details
Keywords: Business Startups; Decision Choices and Conditions; Financial Crisis; Venture Capital; Private Equity; Financing and Loans; Investment; Health Industry; Health Industry
Rhodes-Kropf, Matthew, and Ann Leamon. "Avid Radiopharmaceuticals and Lighthouse Capital Partners." Harvard Business School Case 810-054, September 2009. (Revised September 2010.)
- August 2001
- Case
Scios, Inc.
Scios, filled with distinguished scientists and experienced managers, nevertheless fails to clear the FDA Phase III process for an important biotechnology drug. This case asks the students to analyze the social costs and benefits of the regulatory process. View Details
- 11 Sep 2012
- First Look
First Look: September 11
Michael Beer and Lynda St. ClairHarvard Business School Case 913-521 A new Dallas-based health and beauty spa aims to use a highly distinctive human resource system as the foundation of its competitive strategy. By encouraging employees... View Details
Keywords: Sean Silverthorne
- 07 Oct 2014
- News
Network Effect
Henry McCance, founder (left), and Tim Armour, President & CEO, of Cure Alzheimer's Fund Twelve years ago, when Henry McCance (MBA 1966) and his wife initially faced her diagnosis of Alzheimer’s disease, the couple consulted some of the world’s top physicians... View Details
Keywords: Linda Kush
- 15 May 2012
- News
Finally Finding the Right Fit
Heffernan: From one who's tried on many hats, a tip of the cap to HBS. Photo courtesy Andrew Heffernan As a young man in Dublin, Ireland, Andrew Heffernan (MBA 2006) worked in a variety of summer jobs with the family business, the country’s largest retailer. But... View Details
- 23 Jan 2018
- First Look
First Look at New Research and Ideas, January 23, 2018
consequence of actual leverage than it is of risk premiums. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=53733 2017 India as a Pioneer of Innovation The Private Provision of Missing Public Goods: Evidence from Narayana View Details
Keywords: Sean Silverthorne
- 04 Oct 2017
- Blog Post
What Should German Applicants Know about HBS?
Before attending HBS, German native Charlotte Pallua spent three years at The Boston Consulting Group in Munich where she worked on a variety of health care related projects in Tokyo, London, Miami, and Latin America. We checked in with... View Details
- September 2010
- Teaching Note
Acumen Fund: Measurement in Impact Investing (TN) (A) and (B)
By: Alnoor Ebrahim
Teaching Note for 310011 and 310017. View Details
- 01 Sep 2013
- News
Who Are We?
vertically integrated, local market. In technology, capital flows to the location where products can be produced most quickly and cheaply for the moment; our model focuses on the long-term sustainability that comes from the health of the... View Details
- 17 Oct 2019
- News
Venturing Away from Venture Capital
Life Science Entrepreneurship in 2015, she worked for several venture capital firms specializing in health care and technology startups.) In order to satisfy the limited partners that supply their capital, Unger explains, venture... View Details
Keywords: Alexander Gelfand
- 03 Dec 2008
- What Do You Think?
Can Housing and Credit be “Nudged” Back to Health?
refinancing. These recommendations fall at the intersection of financial and social engineering. They raise the question of whether housing and credit can be "nudged" back to health in this manner or whether there is some better... View Details
Keywords: by Jim Heskett
- January 2021 (Revised June 2021)
- Case
Hester Pharmaceuticals (A): A Pricing Dilemma
By: Dante Roscini and John Masko
In August 2019, the leadership of Hester Pharmaceuticals (Hester) had a problem. Italy promised to be a key market for their new breakthrough oncology drug Akrozumab, but for almost two years, its single-payer healthcare system had been unable to agree with Hester on a... View Details
Keywords: Macroeconomics; Trade; Price; Global Range; Global Strategy; Globalized Markets and Industries; Health Care and Treatment; Patents; Monopoly; Negotiation; Business and Government Relations; Risk and Uncertainty; Human Needs; Business Strategy; Commercialization; Pharmaceutical Industry; Italy
Roscini, Dante, and John Masko. "Hester Pharmaceuticals (A): A Pricing Dilemma." Harvard Business School Case 721-001, January 2021. (Revised June 2021.)